The funds from this round provides the company with the cash runway to cover Imugene’s entire clinical trial pipeline through to the end of 2025, not accounting for other potential revenue streams that may arise.
PH is hinting at potential partnership deal along the way to 2025
Media Thread, page-3806
-
- There are more pages in this discussion • 11,939 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.8¢ | $150.4K | 3.078M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 74 | 9802652 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 1043497 | 13 |
View Market Depth
| Last trade - 10.49am 09/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |